3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Rectal Neoplasms
5
Prostatic Neoplasms
4
Endometrial Neoplasms
4
Colorectal Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thymoma
2
Obesity, Morbid
2
Neoplasms
2
Kidney Neoplasms
2
Genital Diseases, Female
2
Esophageal Neoplasms
2
Uterine Prolapse
1
Uterine Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Diseases
1
Precancerous Conditions
1
Pelvic Organ Prolapse
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Mediastinal Neoplasms
1
Lymphatic Metastasis
1
Interventions
telapristone acetate
18
ulipristal acetate
17
Uterine Myomectomy
13
vilaprisan
12
Leuprolide
11
relugolix
9
estradiol, norethindrone drug combination
9
asoprisnil
9
elagolix
7
Uterine Artery Embolization
7
Mifepristone
7
Estradiol
7
Bupivacaine
7
ulipristal
6
Tranexamic Acid
6
Saline Solution
5
Norethindrone Acetate
5
linzagolix
4
epigallocatechin gallate
4
Sodium Chloride
4
Letrozole
4
Hysterectomy
4
Vitamin B 6
3
Sugars
3
Misoprostol
3
Lidocaine
3
Gonadotropin-Releasing Hormone
3
Embolization, Therapeutic
3
cetrorelix
2
Vitamin D
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Leiomyoma
×
Robotic Surgical Procedures
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled